Campbell David Alan 13D and 13G filings for Janux Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:01 pm Purchase |
2024-09-30 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,644,622 4.800% |
99,547 (+3.91%) |
Filing |
| 2024-02-09 4:31 pm Purchase |
2023-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,545,075 5.300% |
165,140 (+6.94%) |
Filing |
| 2023-02-10 4:32 pm Purchase |
2022-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,379,935 5.400% |
103,323 (+4.54%) |
Filing |
| 2022-02-11 4:01 pm Purchase |
2021-12-31 | 13G | Janux Therapeutics, Inc. JANX |
Campbell David Alan | 2,276,612 5.500% |
2,276,612 (New Position) |
Filing |